Back
Aclaris Therapeutics Vs. Incyte Industry Stock Comparison
Sell
24
ACRS
Aclaris Therapeutics
Last Price:
1.36
Seasonality Move:
-1.77%
Buy
61
INCY
Incyte
Last Price:
54.39
Seasonality Move:
3.6%
Sell
24
Aclaris Therapeutics (ACRS)
is a Sell
Is Aclaris Therapeutics a Buy, Sell or Hold?
- The current Aclaris Therapeutics [ACRS] share price is $1.36. The Score for ACRS is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- ACRS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Incyte (INCY)
is a Buy
Is Incyte a Buy, Sell or Hold?
- The current Incyte [INCY] share price is $54.41. The Score for INCY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- INCY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACRS Stock Price Chart
What is Aclaris Therapeutics's stock price today?
-
The Aclaris Therapeutics share price today is $1.36
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACRS is experiencing buying pressure, which is a positive indicator for future bullish movement.
INCY Stock Price Chart
ACRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 64.34 | Buy |
| Chaikin Money Flow: | 691155 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.18 - 1.28) | Buy |
| Bollinger Bands (100): | (1.08 - 1.28) | Buy |
INCY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.62 | Sell |
| Relative Strength Index (14 RSI): | 53.96 | Buy |
| Chaikin Money Flow: | -102346 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.09 - 54.73) | Buy |
| Bollinger Bands (100): | (54.84 - 62.32) | Sell |
ACRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.28 | Buy |
| 20-day SMA: | 1.24 | Buy |
| 50-day SMA: | 1.23 | Buy |
| 200-day SMA: | 3.44 | Sell |
| 8-day EMA: | 1.3 | Buy |
| 20-day EMA: | 1.26 | Buy |
| 50-day EMA: | 1.27 | Buy |
| 200-day EMA: | 3.47 | Sell |
INCY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.07 | Buy |
| 20-day SMA: | 52.97 | Buy |
| 50-day SMA: | 55.92 | Sell |
| 200-day SMA: | 58.85 | Sell |
| 8-day EMA: | 53.37 | Buy |
| 20-day EMA: | 53.51 | Buy |
| 50-day EMA: | 55.24 | Sell |
| 200-day EMA: | 59.43 | Sell |
Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.05 per share, an increase this year of $0.55 per share, and an increase next year of $0.30 per share.
Incyte Earnings Growth & INCY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.18 per share, an increase this year of $0.70 per share, and an increase next year of $0.99 per share.
Aclaris Therapeutics Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Incyte Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||